Table 3.
Distribution of the type of antiretroviral follow-up (private practice, hospital, or mixed) in French Guiana between 2016 and 2020 among precarious patients.
Year | Private follow-up n (%)* | Hospital follow-up n (%) | Mixed follow-up n (%)** | Total number of patients followed | Annual rate of change (%) |
---|---|---|---|---|---|
2016 | 137 (9.11) | 974 (64.76) | 393 (26.13) | 1,504 | |
2017 | 140 (8.98) | 1,064 (68.25) | 355 (22.77) | 1,559 | 3.66 |
2018 | 185 (10.61) | 1,078 (61.85) | 480 (27.54) | 1,743 | 11.8 |
2019 | 210 (10.97) | 1,178 (61.51) | 527 (27.52) | 1,915 | 9.87 |
2020 | 265 (14.15) | 1,082 (57.77) | 526 (28.08) | 1,873 | −2.19 |
Source: SNDS/DCIR—Beneficiaries of Couverture Maladie Universelle Complémentaire/Complémentaire Santé Solidaire and Aide Médicale Etat in French Guiana.
Linear trend chi2 (private vs. hospital only, 2016–2020): p < 0.001;
Linear trend chi2 (mixed private+hospital vs. hospital only, 2016–2020): p = 0.003.
Because of trend distortions resulting from COVID-19, the trend was recalculated for 2016–2019, excluding 2020.
*Linear trend chi2 (private vs. hospital only, 2016–2009): p = 0.004; **Linear trend chi2 (mixed private+hospital vs. hospital only, 2016–2020): p = 0.002.